Vireo Growth (VREOF) Asset Utilization Ratio (2021 - 2026)
Vireo Growth (VREOF) posted Asset Utilization Ratio of 0.4 for Q1 2026, up 11.74% sequentially from 0.36 in Q4 2025, and up 11.8% YoY from 0.36 in Q1 2025.
Vireo Growth (VREOF) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Vireo Growth has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.4 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 11.8% year-over-year to 0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.4 (up 11.8% YoY) and the FY2025 annual result came in at 0.49, up 14.02% from the prior year.
- Asset Utilization Ratio grew to 0.4 in Q1 2026 per VREOF's latest filing, from 0.36 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.51 in Q2 2024 and troughed at 0.26 in Q2 2025.
- A 5-year average of 0.42 and a median of 0.42 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio surged 41.51% in 2023, then tumbled 48.45% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.45 in 2022, then grew by 10.63% to 0.5 in 2023, then dropped by 15.33% to 0.42 in 2024, then declined by 14.56% to 0.36 in 2025, then advanced by 11.74% to 0.4 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.4, 0.36, and 0.28 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Vireo Growth | 492.35 Mn | 350.05 Mn | 95.30 Mn | 0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.40 |
| Dec 31, 2025 | 0.36 |
| Sep 30, 2025 | 0.28 |
| Jun 30, 2025 | 0.26 |
| Mar 31, 2025 | 0.36 |
| Dec 31, 2024 | 0.42 |
| Sep 30, 2024 | 0.51 |
| Jun 30, 2024 | 0.51 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.50 |
| Sep 30, 2023 | 0.49 |
| Jun 30, 2023 | 0.48 |
| Mar 31, 2023 | 0.49 |
| Dec 31, 2022 | 0.45 |
| Sep 30, 2022 | 0.40 |
| Jun 30, 2022 | 0.39 |
| Mar 31, 2022 | 0.35 |
| Dec 31, 2021 | 0.33 |
| Sep 30, 2021 | 0.38 |
| Jun 30, 2021 | 0.44 |